The recipe is two ingredients. The risk is everything else.
Bacteriostatic water is sterile water plus 0.9% benzyl alcohol. That simplicity drives a persistent question in peptide communities: why not make it at home? The answer comes down to what "sterile" and "0.9%" actually require at a pharmaceutical level — and why falling short of either standard creates contamination risk that is invisible until something goes wrong.
Research-context information only. Bacteriostatic water for injection is a sterile-product category subject to FDA labeling and manufacturing standards. The information below reports what is documented across pharmaceutical references, USP standards, and community discussions. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
The short answer
Technically possible. Practically inadvisable. The formulation itself is simple, but the production environment required to make it safe for injection is not something a home kitchen or garage lab can replicate. Published pharmaceutical manufacturing standards exist specifically because the margin between "looks clean" and "is sterile" is the difference between a safe injection and a fever, abscess, or systemic infection.
The cost math seals it: pharmaceutical-grade bacteriostatic water runs approximately $35 per 30 mL vial — enough to reconstitute roughly 15 peptide vials. The savings from DIY are negligible. The downside risk is not.
What the "recipe" involves
The formulation described across pharmaceutical references and community forums is straightforward:
- Sterile water for injection (not distilled water, not purified water — sterile water for injection, USP)
- Benzyl alcohol at 0.9% concentration by volume (9 mg/mL)
- Combined in a sterile, pyrogen-free container under aseptic conditions
The process people describe online typically involves:
- Sourcing sterile water for injection (sometimes substituted with distilled water — a critical error)
- Calculating the benzyl alcohol volume (0.9 mL per 100 mL of final solution, or 0.27 mL per 30 mL)
- Combining in a vial or container using a syringe and filter needle
- Sealing and storing refrigerated
On paper, this looks manageable. In practice, every step introduces contamination vectors that pharmaceutical manufacturing is specifically engineered to eliminate.
Why DIY is risky: four failure points
1. Sterility is not cleanliness
The single largest risk in homemade bacteriostatic water is microbial contamination. A clean kitchen counter is not a sterile environment. Pharmaceutical-grade injectable products are manufactured under ISO Class 5 (Class 100) cleanroom conditions using laminar flow hoods that maintain unidirectional HEPA-filtered air across the work surface.
The 2012 New England Compounding Center outbreak documented what happens when even professional compounding environments fall short of sterility standards — contaminated injectable methylprednisolone resulted in 751 fungal infections and 64 deaths across 20 states. That facility had equipment, trained staff, and regulatory oversight. A home environment has none of these controls.
Benzyl alcohol at 0.9% concentration inhibits bacterial growth in an already-sterile solution. It does not sterilize a contaminated one. If bacteria, fungi, or particulates are introduced during DIY production, the benzyl alcohol preservative cannot eliminate them — it can only slow their reproduction. The distinction between "bacteriostatic" (growth-inhibiting) and "bactericidal" (bacteria-killing) is the reason sterility at the point of production matters more than the preservative itself.
2. Concentration accuracy is harder than it looks
The 0.9% benzyl alcohol target is a narrow window with consequences on both sides:
- Too little benzyl alcohol (below ~0.5%) and the bacteriostatic effect weakens significantly, allowing bacterial growth in the multi-dose vial during the 28-day use window
- Too much benzyl alcohol (above ~2%) and tissue toxicity becomes a concern — published research has documented injection site irritation, tissue damage, and in extreme concentrations, systemic toxicity from benzyl alcohol exposure
For a 30 mL batch, the target benzyl alcohol volume is 0.27 mL — roughly five drops from a standard dropper. Home measuring equipment (syringes, droppers, kitchen scales) introduces enough variance that hitting 0.9% precisely is difficult to verify without analytical chemistry equipment. Pharmaceutical manufacturers use calibrated volumetric instruments and verify final concentration through quality control testing. Home batches skip that verification entirely.
The Cosmetic Ingredient Review panel's safety assessment of benzyl alcohol confirmed that the compound is safe at controlled concentrations but flagged that dose precision matters — the margin between effective preservative and tissue irritant is concentration-dependent.
3. Pyrogen contamination is invisible
Even if a home batch achieves sterility (no living organisms), it can still contain pyrogens — endotoxin fragments from the cell walls of gram-negative bacteria that trigger fever, inflammation, and in severe cases, septic shock when injected.
Pyrogens are not alive. They cannot be removed by filtration through standard 0.22-micron sterile filters (endotoxins are smaller). They cannot be detected visually or by smell. They survive autoclaving. The only way to confirm their absence is through a Limulus Amebocyte Lysate (LAL) assay — a specialized test that pharmaceutical manufacturers run on every production batch per USP Chapter 85 requirements.
Water for injection has a USP endotoxin limit of 0.25 Endotoxin Units (EU) per mL. Water sourced from non-pharmaceutical channels — even if labeled "sterile" — may not meet this threshold. Home producers have no way to test for or verify pyrogen levels without laboratory equipment that costs more than a lifetime supply of pharmaceutical-grade bac water.
4. No quality testing means no safety verification
Pharmaceutical bacteriostatic water undergoes three categories of release testing before it reaches a consumer:
| Test | What it verifies | Home equivalent |
|---|---|---|
| Sterility testing | No viable microorganisms present | None — visual inspection cannot detect microbial contamination |
| Endotoxin testing (LAL) | Pyrogen levels below 0.25 EU/mL | None — requires specialized laboratory assay |
| Particulate testing | Sub-visible particulate matter below USP limits | None — particles below ~50 microns are invisible to the eye |
A home batch skips all three. The result is an injectable solution with unknown sterility status, unknown endotoxin levels, and unknown particulate content. The first indication of a problem is typically a clinical one — injection site reaction, fever, or worse.
What pharmaceutical-grade bac water actually costs
The cost argument for DIY dissolves under basic arithmetic:
| Item | Cost |
|---|---|
| 30 mL USP bacteriostatic water vial | ~$35 |
| Reconstitutions per vial (at 2 mL per peptide vial) | ~15 |
| Cost per reconstitution | ~$2.30 |
A single vial of pharmaceutical-grade bacteriostatic water from a dedicated supplier like BacWaterCatalog.com covers approximately 15 standard peptide reconstitutions. At $2.30 per use, the cost is a rounding error compared to the peptides themselves — most research peptides run $40-150+ per vial.
The DIY "savings" amount to maybe $20-30 total, spread across 15 reconstitutions, in exchange for unknown sterility, unknown pyrogen levels, and unknown concentration accuracy. Published compounding pharmacy literature has documented that contamination events from improperly prepared sterile products carry costs — medical, legal, and human — that dwarf the price of commercial alternatives by orders of magnitude.
